160 related articles for article (PubMed ID: 31769473)
1. SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma.
Jin J; Cheng S; Wang Y; Wang T; Zeng D; Li Z; Li X; Wang J
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1258-1266. PubMed ID: 31769473
[TBL] [Abstract][Full Text] [Related]
2. SRC3 expressed in BMSCs promotes growth and migration of multiple myeloma cells by regulating the expression of Cx43.
Jin J; Wang T; Wang Y; Chen S; Li Z; Li X; Zhang J; Wang J
Int J Oncol; 2017 Dec; 51(6):1694-1704. PubMed ID: 29075794
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway.
Lu L; Chen G; Yang J; Ma Z; Yang Y; Hu Y; Lu Y; Cao Z; Wang Y; Wang X
Biomed Pharmacother; 2019 Apr; 112():108625. PubMed ID: 30784920
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.
Atsuta I; Liu S; Miura Y; Akiyama K; Chen C; An Y; Shi S; Chen FM
Stem Cell Res Ther; 2013; 4(5):111. PubMed ID: 24025590
[TBL] [Abstract][Full Text] [Related]
7. SRC3 Promotes the Protective Effects of Bone Marrow Mesenchymal Stem Cell Transplantation on Cerebral Ischemia in a Mouse Model.
Lei Q; Deng M; Liu J; He J; Lan Z; Hu Z; Xiao H
ACS Chem Neurosci; 2022 Jan; 13(1):112-119. PubMed ID: 34875163
[TBL] [Abstract][Full Text] [Related]
8. Increased apoptosis and peripheral blood mononuclear cell suppression of bone marrow mesenchymal stem cells in severe aplastic anemia.
Chao YH; Lin CW; Pan HH; Yang SF; Weng TF; Peng CT; Wu KH
Pediatr Blood Cancer; 2018 Sep; 65(9):e27247. PubMed ID: 29870142
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Induced Mesenchymal Stromal Cells Exhibit an Enhanced Therapeutic Effect on Radiation-Induced Lung Injury in Mice due to an Increased Proliferation Potential and Enhanced Antioxidant Ability.
Li B; Li C; Zhu M; Zhang Y; Du J; Xu Y; Liu B; Gao F; Liu H; Cai J; Yang Y
Cell Physiol Biochem; 2017; 44(4):1295-1310. PubMed ID: 29183009
[TBL] [Abstract][Full Text] [Related]
10. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells from bone marrow regulate invasion and drug resistance of multiple myeloma cells by secreting chemokine CXCL13.
Zhang G; Miao F; Xu J; Wang R
Bosn J Basic Med Sci; 2020 May; 20(2):209-217. PubMed ID: 31538911
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect and mechanism of mesenchymal stem cells on melanoma cells.
Zhang J; Hou L; Zhao D; Pan M; Wang Z; Hu H; He J
Clin Transl Oncol; 2017 Nov; 19(11):1358-1374. PubMed ID: 28733866
[TBL] [Abstract][Full Text] [Related]
13. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
[TBL] [Abstract][Full Text] [Related]
15. Myeloma cells self-promote migration by regulating TAB1-driven TIMP-1 expression in mesenchymal stem cells.
Rethnam M; Tan DQ; Suda T
Biochem Biophys Res Commun; 2021 Jan; 534():843-848. PubMed ID: 33183761
[TBL] [Abstract][Full Text] [Related]
16. Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.
André T; Najar M; Stamatopoulos B; Pieters K; Pradier O; Bron D; Meuleman N; Lagneaux L
Cancer Immunol Immunother; 2015 Feb; 64(2):213-24. PubMed ID: 25341809
[TBL] [Abstract][Full Text] [Related]
17. Plasma Cell Proliferation Is Reduced in Myeloma-Induced Hypercalcemia and in Co-Culture with Normal Healthy BM-MSCs.
Vazifeh Shiran N; Abroun S
Lab Med; 2021 May; 52(3):273-289. PubMed ID: 33942854
[TBL] [Abstract][Full Text] [Related]
18. Omentin-1 effects on mesenchymal stem cells: proliferation, apoptosis, and angiogenesis in vitro.
Yin L; Huang D; Liu X; Wang Y; Liu J; Liu F; Yu B
Stem Cell Res Ther; 2017 Oct; 8(1):224. PubMed ID: 29017592
[TBL] [Abstract][Full Text] [Related]
19. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
[TBL] [Abstract][Full Text] [Related]
20. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
